ArticleJournal of clinical medicine2026

Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study.

Gerdi Tuli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.